SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Zhang Peng — LightRocket via Getty Images

35

Johnson & Johnson

JNJ

As the world’s biggest health care products company, Johnson & Johnson has massive scope: a sampling of its products includes Benadryl, Band-Aids, Neutrogena, Tylenol, Motrin, and Listerine. How do you boost something that’s already big? Acquisitions and revenue growth (notably in beauty products). While domestic sales rose 6%, international sales decreased about 1% thanks to divestitures, currency issues, and upheaval in Venezuela. Even if the international climate gets more comfortable, the company long known for its pioneering innovation could face competition from generics that could eat into sales.

Looking for leads, investment insights, or competitive intelligence?

CEO

Alex Gorsky

CEO Title

Chairman & Chief Executive Officer

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New Brunswick, NJ

Years on Fortune 500 List

23

Employees

126,400

Profile provided by S&P Global.
Johnson & Johnson is also featured in these fortune lists
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$71,8902.6%
Profits ($M)$16,540.07.3%
Assets ($M)$141,208
Total Stockholder Equity ($M)$70,418
Market Value — as of March 31, 2017 ($M)$337,642
Profit Ratios
Profit as % of Revenues23.0%
Profits as % of Assets11.7%
Profits as % of Stockholder Equity23.5%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)5.93
EPS % Change (from 2015)8.2%
EPS % Change (5 year annual rate)11.2%
EPS % Change (10 year annual rate)4.7%
Total Return
Total Return to Investors (2016)15.3%
Total Return to Investors (5 year, annualized)15.3%
Total Return to Investors (10 year, annualized)9.0%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Johnson & Johnson

Bill Gates Is Now Tackling Alzheimer’s With a Huge Investment in Dementia Research

He'll put in $50 million to start, with plans to invest at least another $50 million.

Read More →
Johnson & Johnson Wins Reversal of $72 Million Verdict Over Talc Cancer Risks

The February 2016 verdict was the first of four jury awards totaling $307 million.

Read More →
5 Rules Digital Marketers at J&J, SoFi, J.P. Morgan, and IBM Swear By

Key takeaways from Fortune's Most Powerful Women Summit

Read More →
The FDA Has Created an Approval "Fast-Track" for Apple, Samsung, and Fitbit

The move is meant to expedite the FDA approval process for life-saving technology.

Read More →